2025-05-26
D3X, an AI-powered DeFi infrastructure project, has officially announced that its flagship decentralized trading node product AIBOT will commence its first global presale on May 28, 2024 at 15:00 (UTC+8).
In this round,6000AIBOT nodes will be made available at a unit price of 100 USDT. Each node supports daily mining of the native token $D3XAI, and participants will also share in an exclusive17.5 million pieces $D3XAI early mining reward pool.
AIBOT is a plug-and-play mining node designed for users with no coding experience. It integrates AI-driven trading strategies, market sentiment analysis, and multi-chain DeFi routing execution to deliver stable and sustainable on-chain returns. The monthly operating cost per node is 38 USDT (covering data subscription and hosting).
$D3XAI follows a 10-year linear emission schedule, with higher early issuance rates. D3X plans to expand its ecosystem by introducing additional AI task models, strategy plugin modules, and multi-chain compatibility, building out a decentralized AI computing network.
Website: https://d3xai.ai
Twitter: https://x.com/D3X_AI
Telegram: https://t.me/D3X_AI
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright2009-2020Fresh life